Regulations.gov document
Clinical Considerations for Studies of Devices Intended To Treat Opioid Use Disorder…
Notice · FDA-2023-D-0466 · posted Jul 11, 2024
Key facts
| Document ID | FDA-2023-D-0466-0016 |
|---|---|
| Title | Clinical Considerations for Studies of Devices Intended To Treat Opioid Use Disorder; Guidance for Industry and Food and Drug Administration Staff; Availability |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2023-D-0466 |
| Posted | Jul 11, 2024 |
| Federal Register citation | 89 FR 56886 |
| FR document number | 2024-15130 |
| Comment period opens | Jul 11, 2024 |
| Effective date | Jul 11, 2024 |
At a glance
- 1–9 Pages
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: